David-Alexandre C Gros insider trades

Open-market stock purchases and sales by David-Alexandre C Gros, Chief Executive Officer at Eledon Pharmaceuticals, Inc, from SEC Form 4 filings since Jun 8, 2015.

Track record: 100% of 2 scored buys are up 5% or more since purchase, averaging +298%.

Recent trades

No open-market trades in the last 12 months.

Companies traded

  • ELDN Eledon Pharmaceuticals, Inc: 3 buys, last Jan 10, 2025
  • NVUS Novus Therapeutics, Inc: other filings, last Sep 11, 2020
  • NBIX Neurocrine Biosciences Inc: other filings, last Feb 6, 2017
  • ALNY Alnylam Pharmaceuticals, Inc: 2 buys, last Dec 20, 2016

Get free alerts when David-Alexandre C Gros files a new trade →